Products

What will AGI do for Amphetamine aspartate?

This classification denotes a cns stimulant with the molecular formula 2C9H13N.C4H7NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H527KAP6L5, chemically known as l-aspartic acid, compd. with alpha-methylbenzeneethanamine (1:2) but more generally known as amphetamine aspartate, which bears US NIH Compound Identifier 32892. European Medicines Agency schedules Amphetamine aspartate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB33384. Most nations, for tariff and trade purposes, schedule amphetamine aspartate under HS 29214600. As of Q4 2014, AMPHETAMINE ASPARTATE remains US FDA's Preferred Term for this commodity. Amphetamine aspartate bears US NLM identifiers UMLS ID C0724524 and NCI Concept Code C61636. SMILES: CC(CC1CCCCC1)N.CC(CC1CCCCC1)N.C([C@@H](C(=O)O)N)C(=O)O.

How AGI delivers it

Four ways AGI delivers for Amphetamine aspartate

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Amphetamine aspartate, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Amphetamine aspartate, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Amphetamine aspartate connects

measured by

  • Assay Puritymodel
  • Impurity Contentmodel
  • Moisture Contentmodel
  • Residual Solventmodel